Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is a global epidemic without effective therapeutic agents in the clinic. This meta-analysis aimed to assess the efficacy of the marketed hepatoprotectant bicyclol at improving blood biomarkers in patients with NAFLD. DESIGN: Electronic databases w...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hu, Liu, Nan-Nan, Peng, Zong-Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Complementary Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722377/
https://www.ncbi.nlm.nih.gov/pubmed/33277283
http://dx.doi.org/10.1136/bmjopen-2020-039700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722377/
https://www.ncbi.nlm.nih.gov/pubmed/33277283
http://dx.doi.org/10.1136/bmjopen-2020-039700

Ejemplares similares